Omega Diagnostics Group PLC
ODX.L · LSE
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.13 | 0.87 | 0.00 |
| FCF Yield | -4,610.01% | -66.94% | -3.79% | -15.02% |
| EV / EBITDA | 1.88 | 16.10 | -55.52 | -2.18 |
| Quality | ||||
| ROIC | -21.14% | -5.98% | -7.10% | -1.50% |
| Gross Margin | 46.98% | 59.75% | 51.04% | 64.10% |
| Cash Conversion Ratio | 0.82 | 0.28 | 1.15 | -0.08 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.76% | -4.55% | -0.08% | -10.19% |
| Free Cash Flow Growth | 29.79% | 10.24% | -226.49% | 30.93% |
| Safety | ||||
| Net Debt / EBITDA | 1.90 | -3.43 | 1.23 | -0.63 |
| Interest Coverage | -208.85 | -28.19 | -15.23 | -1.24 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 3.14 | 0.00 | 0.00 |
| Cash Conversion Cycle | -139.12 | -167.79 | -270.77 | -165.72 |